➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Express Scripts
Moodys
AstraZeneca
Medtronic

Last Updated: January 24, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020950

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 020950 describes DUONEB, which is a drug marketed by Mylan Speciality Lp and is included in one NDA. There is one patent protecting this drug. Additional details are available on the DUONEB profile page.

The generic ingredient in DUONEB is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.
Summary for 020950
Tradename:DUONEB
Applicant:Mylan Speciality Lp
Ingredient:albuterol sulfate; ipratropium bromide
Patents:1
Paragraph IV (Patent) Challenges for 020950
Tradename Dosage Ingredient NDA Submissiondate
DUONEB SOLUTION;INHALATION albuterol sulfate; ipratropium bromide 020950

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INHALATIONStrengthEQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Mar 21, 2001TE:RLD:Yes
Patent:  Start TrialPatent Expiration:Dec 28, 2021Product Flag?Substance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Harvard Business School
McKinsey
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.